BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023

  CTI BioPharma Corp. today announced that its fourth quarter and full year 2022 financial results will be reported on Monday, March 6, 2023, after the close of the financial market.

  February 23, 2023

   · 

  1 min read
• Business

  OKYO Pharma Announces Appointment of Dr. Jay S. Pepose to Its Scientific Advisory Board

  OKYO Pharma Limited announces the appointment of Jay S. Pepose, M.D., Ph.D., Founder and Medical Director of the Pepose Vision Institute and Professor of Clinical Ophthalmology at Washington University School of Medicine, to OKYO’s Scientific Advisory Board.

  February 23, 2023

   · 

  4 min read
• ViiV Healthcare Announces Positive Data Demonstrating Long-acting Injectable Cabenuva (cabotegravir, rilpivirine) is as Effective as Daily Oral Biktarvy (BIC/FTC/TAF) for the Treatment of HIV-1

  ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced positive 12-month findings from the SOLAR study.

  February 23, 2023

   · 

  10 min read
• Genetown

  Biophytis To Host a Combined General Shareholder’s Meeting on March 30, 2023

  Biophytis SA announced it is convening an Extraordinary and Ordinary Shareholders’ Meeting for March 30, 2023.

  February 23, 2023

   · 

  3 min read
• Business

  Immunovia Publishes Full Year Report for 2022

  In Q4, Immunovia continued to execute on its unique position as a leader in innovative early detection of pancreatic cancer.

  February 23, 2023

   · 

  10 min read
• Medivir to present at the Erik Penser Bank Healthcare Day - February 23, 2023

  Medivir AB announces that the company will present at the Erik Penser Bank Healthcare Day today, February 23, 2023.

  February 23, 2023

   · 

  1 min read
• Business

  Immunic, Inc. Reports Year End 2022 Financial Results and Provides Corporate Update

  Immunic, Inc. (NASDAQ: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced financial results for the year ended December 31, 2022, and provided a corporate update.

  February 23, 2023

   · 

  14 min read
• Business

  Agios Reports Fourth Quarter and Full Year 2022 Financial Results

  Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for rare diseases, reported business highlights and financial results for the fourth quarter and year ended Dec. 31, 2022.

  February 23, 2023

   · 

  11 min read
• Drug Development

  Atea Pharmaceuticals Presents Favorable Drug Interaction Profile of Bemnifosbuvir in Phase 1 Studies at CROI 2023

  Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that data from three Phase 1 studies suggest a favorable drug-drug interaction profile.

  February 23, 2023

   · 

  6 min read
• Business

  Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023

  Chimerix (NASDAQ:CMRX) today announced that it will host a live conference call and audio webcast on Thursday, March 2, 2023 at 8:30 a.m. ET to report financial results for the fourth quarter and full-year ended December 31, 2022, and to provide a business overview.

  February 23, 2023

   · 

  1 min read